Measles Cases Are Spreading in the US—Here’s What to Know

Melissa Suran

DOI: https://doi.org/10.1001/jama.2024.1949

IF: 11.816

2024-02-28

JAMA

Abstract:This Medical News article discusses measles cases spreading in the US.

medicine, general & internal

What problem does this paper attempt to address?

Quantifying the risk of measles importation and spread in the United States in 2024

Subekshya Bidari,Haokun Yuan,Wan Yang

DOI: https://doi.org/10.1101/2024.06.06.24308559

2024-06-07

Abstract:Measles outbreaks have increased globally following the COVID-19 pandemic. We combine multiple data sets on global measles incidence, air travels, and vaccinations to assess the risk of travel-related importation and subsequent dissemination of measles in the United States in 2024, and identify months and states with higher measles outbreak risks.
The Resurgence of Measles: A Rash From the Past

Michael D Gooch

DOI: https://doi.org/10.1097/TME.0000000000000521

Abstract:Measles, or rubeola, remains a highly contagious infectious disease with a concerning resurgence in the United States. Despite previous control efforts, the number of reported cases continues to rise, surpassing the total for the previous year in just the first quarter of 2024 (CDC, 2024a). Emergency nurse practitioners and other emergency clinicians are likely to encounter patients presenting with concerns of or exposure to measles. However, given the low frequency of cases in the past, many emergency clinicians have likely not previously encountered measles, making identification more challenging. Early recognition and isolation are paramount in containing the spread of this virus and mitigating potential complications. This article aims to provide a review of measles, covering its pathophysiology, clinical presentations, and recommended management strategies for suspected or confirmed cases in emergency care settings.
Epidemiologic Analysis of a Postelimination Measles Outbreak in Ohio, 2022-2023

Rosemary A. Martoma,Matthew Washam,Hinda Omar,Ava R. Martoma,Randal De Souza,Sagar Kumar,Robert D. Sege,Emily E. Ricotta,Maimuna S. Majumder

DOI: https://doi.org/10.1001/jamanetworkopen.2024.29696

2024-08-28

JAMA Network Open

Abstract:Importance Postelimination outbreaks threaten nearly a quarter century of measles elimination in the US. Understanding these dynamics is essential for maintaining the nation's measles elimination status. Objective To examine the demographic characteristics and transmission dynamics of the 2022 to 2023 central Ohio measles outbreak. Design, Setting, and Participants This cross-sectional study used electronic medical records and publicly available measles reports within an extensive central Ohio primary care network involving inpatient and outpatient settings. Participants included 90 children in Ohio with confirmed measles cases in 2022. Exposure The exposure of interest was confirmed measles cases in Ohio in 2022. This included 5 internationally imported cases and 85 locally acquired cases. Main Outcomes and Measures The primary outcome involved documenting and analyzing confirmed measles cases in Ohio in 2022, focusing on demographic characteristics, immunization status, and transmission links in outbreak-related cases. Results This study analyzed 90 measles cases (47 [52.2%] male participants) in Ohio during 2022. Most participants self-identified as African or American Black (72 [80.0%]), with additional race categories including Asian, Hispanic, multirace (6 [6.7%]), White, and unknown (6 [6.7%]). Most participants were of Somali descent (64 [71.1%]), with additional ethnicity categories including American (16 [17.8%]), Guatemalan, Nepali, and unknown (6 [6.7%]). Participants were predominantly younger than 6 years (86 [95.5%]), unimmunized (89 [98.9%]), and resided in Franklin County, Ohio (83 [92.2%]). Prior to November 20, 2022, all cases occurred among unimmunized children of Somali descent in the Columbus area. Nosocomial superspreading events expanded the outbreak beyond the initially affected community. Conclusions and Relevance This cross-sectional study of measles cases in Ohio during 2022 found that the outbreak primarily affected unimmunized children of Somali descent, highlighting the necessity for culturally tailored public health strategies to maintain measles elimination in the US. These findings underscore the importance of implementing targeted interventions and enhancing community engagement to increase vaccination rates.

medicine, general & internal
What to Know About Monkeypox

Emily Harris

DOI: https://doi.org/10.1001/jama.2022.9499

2022-06-22

Abstract:This Medical News feature discusses what experts know so far about growing outbreaks in the US and other countries.
A Call to Action: Strengthening Vaccine Confidence in the United States

Sarah Mbaeyi,Amanda Cohn,Nancy Messonnier

DOI: https://doi.org/10.1542/peds.2020-0390

2020-05-27

PEDIATRICS

Abstract:* Abbreviation: CDC — : Centers for Disease Control and PreventionIn the United States and around the world, measles (a serious, potentially fatal, and extremely contagious infection) was considered a disease of the past until recently. However, what was once old news is now making headlines again with a remarkably predictable storyline: when immunity to measles falls in a population, outbreaks soon follow. This scenario has unfolded in places such as Ukraine, the Philippines, Israel, and Samoa with devastating consequences.1 In 2019 alone, the United Kingdom and 3 other European countries lost measles elimination status in part because of vaccine hesitancy, or the delay in acceptance or the refusal of vaccination despite availability of vaccination services, which was named one of the top global public health threats by the World Health Organization. Amid this global measles resurgence, the United States experienced a chain reaction of measles cases imported into close-knit, undervaccinated communities (primarily by unvaccinated US residents carrying measles home from outbreaks abroad), leading to outbreaks across the country in 2018 and 2019. These outbreaks were fueled by targeted vaccine misinformation and resulted in the highest number of measles cases in almost 30 years, nearly costing the United States its measles elimination status.2 To protect our nation, we need to change this narrative. We must empower families, in all … Address correspondence to Sarah Mbaeyi, MD, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop H24-8, Atlanta, GA 30329. E-mail: smbaeyi{at}cdc.gov

pediatrics
Measles surge causes alarm: what scientists think

Carissa Wong

DOI: https://doi.org/10.1038/d41586-024-00265-8

IF: 64.8

2024-02-01

Nature

Abstract:A drastic rise in infections in the United Kingdom and Europe follows a drop in vaccine uptake. A drastic rise in infections in the United Kingdom and Europe follows a drop in vaccine uptake.

multidisciplinary sciences
Measles hospitalizations, United States, 1985-2002

Brent Lee,Michelle Ying,Mark J Papania,John Stevenson,Jane F Seward,Sonja S Hutchins

DOI: https://doi.org/10.1086/381555

Abstract:Cases of measles that require hospitalization are a good marker of the burden of clinically severe measles in the United States. Measles hospitalizations routinely are monitored by the National Notifiable Disease Surveillance System (NNDSS). Our objectives were to describe measles hospitalizations reported to the NNDSS in 1985-2002, to use hospital discharge data from independent data sets (the National Hospital Discharge Survey [NHDS] [data available for 1985-1999] and the Health Care Investment Analysts [HCIA] hospital discharge database [data available for 1985-1996]) to provide additional estimates of total measles hospitalizations, and to compare trends in measles-associated hospitalizations. In 1985-2002, a total of 13621 patients with measles reported to the NNDSS were hospitalized (annual average, 757; range, 19-5856 patients). In 1985-1996, a total of 13472 measles hospitalizations were reported from NNDSS, compared with 28047 estimated from the NHDS and 19352 extrapolated from HCIA data. In the NNDSS, the annual total number declined after 1992 to <or=45 measles hospitalizations per year; this trend was closely paralleled by both the NHDS and the HCIA data. We demonstrate a decline in reported measles hospitalizations since the 1989-1991 measles resurgence, with the lowest numbers ever reported in the NNDSS. These numbers are corroborated by the very low numbers of measles hospitalizations in the NHDS and HCIA data.
Public Health Consequences of a 2013 Measles Outbreak in New York City

Jennifer B. Rosen,Robert J. Arciuolo,Amina M. Khawja,Jie Fu,Francesca R. Giancotti,Jane R. Zucker

DOI: https://doi.org/10.1001/jamapediatrics.2018.1024

2018-09-01

JAMA Pediatrics

Abstract:Importance: Internationally imported cases of measles into the United States can lead to outbreaks requiring extensive and rapid control measures. Importation of measles from an unvaccinated adolescent in 2013 led to what has been the largest outbreak of measles in New York City, New York, since 1992.Objective: To describe the epidemiology and public health burden in terms of resources and cost of the 2013 measles outbreak in New York City.Design, Setting, and Participants: This epidemiologic assessment and cost analysis conducted between August 15, 2013, and August 5, 2014, examined all outbreak-associated cases of measles among persons residing in New York City in 2013.Exposures: Measles virus.Main Outcomes and Measures: Numbers of measles cases and contacts. Total personnel time and total direct cost to the New York City Department of Health and Mental Hygiene (DOHMH), calculated as the sum of inputs (supplies and materials, equipment, and logistics) and personnel time (salary and fringe benefits).Results: Between March 13, 2013, and June 9, 2013, 58 persons in New York City with a median age of 3 years (range, 0-32 years) were identified as having measles. Among these individuals, 45 (78%) were at least 12 months old and were unvaccinated owing to parental refusal or intentional delay. Only 28 individuals (48%) visited a medical health care professional who suspected measles and reported the case to the DOHMH at the initial clinical suspicion. Many case patients were not immediately placed into airborne isolation, resulting in exposures in 11 health care facilities. In total, 3351 exposed contacts were identified. Total direct costs to the New York City DOHMH were $394 448, and a total of 10 054 hours were consumed responding to and controlling the outbreak.Conclusions and Relevance: Vaccine refusals and delays appeared to have propagated a large outbreak following importation of measles into the United States. Prompt recognition of measles along with rapid implementation of airborne isolation of individuals suspected of measles infection in health care facilities and timely reporting to public health agencies may avoid large numbers of exposures. The response and containment of measles outbreaks are resource intensive.

pediatrics
Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019

Ruitong Wang,Wenzhan Jing,Min Liu,Jue Liu

DOI: https://doi.org/10.3389/fmed.2021.798031

2022-01-20

Abstract:Background: Measles is a highly contagious disease that has caused global morbidity and mortality. Though great progress has been made in measles elimination, the resurgence of measles has been observed in recent years. As extant literature were mainly confined to data of local area, we conducted a systematic analysis to explore the trends of the incidence of measles, coverage rate, and the risk factors from 1990 to 2019 on global, regional, and national levels. Methods: Data on cases of incidence, age standardized rate (ASR), vaccine coverage, and risk factors of measles were retrieved from the Global Burden of Disease (GBD) Study 2019 database. Estimated averaged percentage change (EAPC) of ASR was calculated to quantify the trends of measles incidence. Pearson correlation was applied to assess the association of EAPC and measles-containing vaccine coverage rate with socio-demographic index (SDI) in 2019, and the correlation between ASR and measles-containing vaccine coverage rate. Results: Globally, there was a significant decrease in the number (84.18%) and ASR (6.13%, 95% CI: 5.41-6.84%) of measles incidence from 1990 to 2019. More than 80% of incidence cases were attributed to children under 5 and the proportion was highest in low SDI region. Countries and territories with low ASRs are mostly clustered in North America, Southern Latin America, and Western Europe, whereas those with high ASRs are mainly clustered in Africa, East Asia, and South Asia. Lower SDI was associated with higher ASR and lower vaccine coverage rate. The more the SDI value was further away from 0.6, the smaller the absolute value did EAPC have. Child wasting accounted for the most measles-related death cases, followed by child underweight, child stunting, and vitamin A deficiency. Conclusions: Measles eradication is feasible, but urgently demands political commitment, financial support, and public engagement. In the context of COVID-19 pandemic and the global resurgence of measles, surveillance systems and routine immunization programs should be improved, while vaccine hesitancy needs to be addressed.
The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Post-Elimination Era, 2001-2022

Jessica Leung,Naeemah A Munir,Adria D Mathis,Thomas D Filardo,Paul A Rota,David E Sugerman,Sun B Sowers,Sara Mercader,Stephen N Crooke,Paul A Gastañaduy

DOI: https://doi.org/10.1093/cid/ciae470

IF: 20.999

2024-09-16

Clinical Infectious Diseases

Abstract:Despite high vaccine-effectiveness, wild-type measles can occur in previously vaccinated persons. We compared the clinical presentation and disease severity of measles by vaccination status and age in the post-elimination era in the United States. We included U.S. measles cases reported from 2001–2022. Breakthrough measles was defined as cases with ≥1 documented dose of measles-containing vaccine, classic measles as the presence of rash, fever, and ≥1 symptoms (cough, coryza, or conjunctivitis), and severe disease as the presence of pneumonia, encephalitis, hospitalization, or death. Vaccinated cases with low and high avidity IgG were classified as primary (PVF) and secondary (SVF) vaccine failures, respectively. Among 4,056 confirmed measles cases, 2,799 (69%) were unvaccinated, 475 (12%) were breakthrough infections, and 782 (19%) had unknown vaccination; 1,526 (38%), 1,174 (29%), and 1,355 (33%) were aged <5, 5–19, and ≥20 years, respectively. We observed a general decline in classic presentation and severe disease with an increase in the number of doses, and less complications among children aged 5–19 years compared to other age-groups. Among 93 breakthrough cases with avidity results, 11 (12%) and 76 (82%) were classified as PVF and SVF, respectively, with a higher proportion of PVFs having a classic measles presentation and severe disease than SVFs. Breakthrough measles cases tended to have milder disease with less complications. A small proportion of breakthrough infections were due to PVF than SVF. It is critical to maintain high MMR vaccination coverage in the United States to prevent serious measles illnesses.

immunology,infectious diseases,microbiology
Measles Outbreak in Lebanon: July 2023

Mariana Helou,Yara Mouawad,Fadi El Ters,Rola Husni

DOI: https://doi.org/10.1017/dmp.2024.42

IF: 5.556

2024-03-27

Disaster Medicine and Public Health Preparedness

Abstract:After the beginning of the Syrian crisis, increased rates of infectious diseases were reported. Lebanon, a neighboring country with a major socioeconomic crisis, witnessed a measles outbreak since July 2023, with 519 reported suspected cases. Half of the cases were under 5 y of age, most of them were unvaccinated. The mass displacement of refugees from conflict areas in Syria to Lebanon and the low vaccination coverage have made the situation more challenging. Further efforts are required in Lebanon to address identified gaps to prevent or at least better control future outbreaks.

public, environmental & occupational health
Ongoing Measles in the Developed and Developing World

James D Cherry

DOI: https://doi.org/10.1093/jpids/piae018

2024-02-29

Journal of the Pediatric Infectious Diseases Society

Abstract:Abstract Measles is a vaccine preventable illness. Nevertheless, in recent years, measles is still endemic and epidemic in both the developed world and the developing world. The public perception of measles in the past was that it was not a big deal. However, measles is associated with a number of complications which can be places in three categories which are: acute(diarrhea, otitis media, pneumonia, encephalitis, seizures, and death) and delayed-subacute sclerosing panencephalitis (SSPE) and post measles immune amnesia. Contrary to the beliefs of the anti-vaccine lobby, measles is bad. In acute measles, the death rate is 1-3 per 1000 and the risk of encephalitis is 1 per 1000. Relatively recent investigations indicate that SSPE is considerably more common than previously believed. The worldwide contribution of post measles immune amnesia to morbidity and mortality is likely to be huge. In exposure situations two doses of measles vaccine will prevent 99% of cases. Presently in the United States the first dose is given at 12 through 15 months of age. The second dose is most often administered at 4 through 6 years of age. In my opinion, the second dose of measles vaccine should be given 4 to 6 weeks after the first dose rather than at 4 to 6 years of age. Children who don’t have antibody to measles should not travel to risk areas.

pediatrics,infectious diseases
Measles outbreak in the adult age group: Clinical, laboratory, and epidemiological features of the 11 patients admitted to the hospital

Kultural Gungor,Sebnem Bukavaz,Galip Ekuklu

DOI: https://doi.org/10.1002/jmv.29583

IF: 20.693

2024-04-06

Journal of Medical Virology

Abstract:The measles virus, also known as the morbillivirus, or MV, is a virus that infects humans. The goal of this research is to assess to adult cases of measles. Eleven patients thought to be confirmed cases of measles were enrolled in the investigation. Following the identification of symptoms of tiredness, fever, and rash in one soldier, the results of 10 more troops from the pertinent military group were assessed. The diagnosis was made based on the presence of serum immunoglobulin M (IgM) and positive polymerase chain reaction (PCR) results. When the control IgM, immunoglobulin G, and PCR findings were evaluated a fortnight after hospitalization, a cluster of 11 incidents was found. It is now necessary to address the issue of the cautious stance towards vaccination or the anti‐vaccination sentiment that has grown increasingly popular, particularly in light of the COVID‐19 pandemic, for both our nation and the entire world.

virology
Measles resurgence in Armenia: unmasking health system vulnerabilities and crafting comprehensive eradication strategies - a review

Marlyn Susan George,Hamza Rafique Khan,Sheetal Khadka,Rohit Chandra Dey,Sworup Khadka,Diana F Sánchez-Velazco,Sarbagya Manandhar,Harendra Kumar,Shahzaib Ahmed

DOI: https://doi.org/10.1097/MS9.0000000000002413

2024-08-06

Abstract:Measles is an acute febrile illness associated with rashes, fever and life-threatening complications. It is a vaccine-preventable disease with the Measles Mumps Rubella(MMR) vaccine but a recent global trend unveils a resurgence of measles in various parts of the world including Armenia. Measles was declared eliminated from Armenia in 2021 before reports of local outbreaks surfaced in 2023. The WHO identified discrepancies in the vaccination coverage during COVID-19. Measles also poses a great financial burden as a public health issue worldwide. Sociocultural factors impacting measles transmission are maternal education, healthcare access, migration, vaccine hesitancy, and socioeconomic status (Table 3). Efforts to control and eradicate measles from Armenia are run by a collaborative approach of national and international health bodies such as United Nations Children's Fund (UNICEF), WHO, Global Vaccine Alliance (GAVI), and the Ministry of Health. Thus, the resurgence of measles can be managed through widespread patient education, innovative approaches, strengthening the healthcare system and addressing vaccine hesitancy, sociocultural barriers, and humanitarian emergencies. This review investigates the complicated dynamics of measles inside Armenia's health system in depth. A thorough examination of measles incidence and immunization patterns highlights the shift from few cases and high vaccination rates to a comeback caused by imported viruses. The causes of its recurrence have been thoroughly investigated, including reduced immunization programs and vaccine hesitancy. The research delves further into the 'One Health' idea, assessing the possibility of interspecies transmission among nonhuman primates and examining the environmental factors that influence measles transmission. Among the challenges are weaknesses within Armenia's health system as well as the possibility of interruptions from the COVID-19 outbreak. In measles vaccination status, the combination of maternal education, postnatal care, and socioeconomic variables exposes the larger drivers at work. The study concludes with a comprehensive set of public health policy recommendations covering vaccination promotion, surveillance, healthcare provider education, public awareness, international collaboration, data analysis, law enforcement, emergency preparedness, research, and coordination. The research sheds light on the tangled web of measles dynamics, health system resilience, and contextual subtleties via this multifaceted approach, inviting readers to investigate the multiple strategies required for eliminating measles in Armenia.
Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels — United States, May 2022–April 2023

Christine M. Thomas,Amanda Hartley,Ann Schmitz,Heather D. Reid,Susan Sullivan,Elise Huebner,Meredith Robinson,Adria Mathis,Mary-Margaret A. Fill,Kara J. Levinson,Tim F. Jones,William Schaffner,Caitlin N. Newhouse,John R. Dunn

DOI: https://doi.org/10.15585/mmwr.mm7312a3

2024-03-30

MMWR Morbidity and Mortality Weekly Report

Abstract:This report describes incidental detection of the measles vaccine strain when using syndromic polymerase chain reaction panels on patients who recently received a measles vaccine.

public, environmental & occupational health
Measles and Measles Vaccination: A Review

Johan Christiaan Bester

DOI: https://doi.org/10.1001/jamapediatrics.2016.1787

2016-12-01

Abstract:Importance: Measles is a highly communicable viral infection with serious complications. There have been continued outbreaks of measles in countries in which measles is considered to be eliminated, such as the United States and the Netherlands, and measles remains endemic in some countries. Health care professionals play an important role in diagnosing and managing acute cases of measles, preventing spread during outbreaks, and vaccination uptake. Objective: To provide an overview of measles and vaccination for health care professionals. Evidence review: MEDLINE and PubMed were searched from January 1, 1980, to April 30, 2016, in addition to the data repositories of the Centers for Disease Control and Prevention and World Health Organization. Findings: Seven systematic reviews, 15 reviews, 15 observational studies, 1 qualitative study, 5 epidemiologic reports, and 2 books were included, in addition to World Health Organization and Centers for Disease Control and Prevention data, position papers, and statements. Transmission of measles is dependent on person-to-person spread through respiratory droplets or direct contact. Diagnosis is based on recognizing the clinical picture and can be confirmed with results of laboratory testing, such as serologic tests or polymerase chain reaction. Measles infection leads to immune suppression for weeks to months. Complications of measles are of high frequency and severity. There is no specific antiviral treatment for measles; treatment with vitamin A is recommended for younger children to decrease mortality from measles. Vaccination against measles is effective, cost-effective, and safe. There is no link between the measles vaccination and autism. Measles can be eliminated from a population; this outcome requires coverage with 2 doses of vaccine at rates of 93% to 95% of the population. Countries with high rates of measles vaccination experience outbreaks by virtue of imported cases causing transmission through susceptible groups of individuals who are not immune to the measles virus. Endemic transmission can be reestablished if rates of vaccination fall below the elimination threshold. Conclusions and relevance: Measles remains of high clinical importance. Health care professionals should be able to diagnose and manage an acute case and assist in prevention of the spread of measles during an outbreak. Health care professionals also play an important role in uptake of measles vaccination through establishing trusting relationships with parents, offering vaccination at indicated times, and engaging parents in discussion on facts and concerns about vaccination.
Global resurgence of measles in the vaccination era and influencing factors

Subekshya Bidari,Wan Yang

DOI: https://doi.org/10.1016/j.ijid.2024.107189

Abstract:Objectives: Recent years have seen increased cases of measles despite widespread vaccination. We examined the potential drivers behind the resurgence of measles. Methods: We analyzed the trends in measles incidence and vaccine coverage from 2010 to 2019 across World Health Organization member countries using country-level linear regression models. We computed the Spearman rank correlation coefficient (ρ) between measles incidence and socioeconomic and vaccination-related variables using published data from the World Health Organization member countries to identify the key factors influencing measles incidence. Results: Between 2010 and 2019, global measles cases fluctuated, with a notable rise in 2019 (measles cases per million in 2019 was about 140% higher than in 2010), alongside a declining vaccination coverage in many countries (59 of 194 countries). Among 10 socioeconomic factors examined, per-capita national gross income, population literacy, urban residences, and political stability were significantly associated with measles incidence (ρ <0, and P <0.05 for all these variables). These factors likely reflect the quality of public health infrastructure (e.g. access to vaccines), particularly, in low- and middle-income countries. In addition, a stratified analysis suggests vaccine hesitancy likely contributed to measles case increases in high- and upper middle-income countries. Conclusions: The socioeconomic determinants of measles transmission are interconnected and region-specific. The availability of public health resources and political stability significantly influence measles burdens in low- and middle-income countries, whereas vaccine hesitancy presents a unique challenge to measles elimination in high- and upper middle-income countries.
The Next Outbreak Looms on the Horizon: Measles and Potential Impacts on Transplant Recipients

Ayman Al Jurdi,Camille N. Kotton

DOI: https://doi.org/10.1097/tp.0000000000005083

2024-09-26

Transplantation

Abstract:Significant outbreaks of measles are occurring throughout the world, including the United States, the United Kingdom, India, and other areas with significant rates of organ transplantation, fed in part by vaccine reluctance and lower rates of childhood vaccination. 1 , 2 Measles is transmitted via airborne spread or respiratory droplets and is among the most contagious of pathogens with infection occurring in up to 90% of nonimmune close contacts 3 ; a single case of infection is estimated to cause 12–18 secondary cases in susceptible individuals 1 , 4 and may be even more contagious in susceptible immunocompromised populations. Measles typically presents with fever, maculopapular rash, conjunctivitis, cough, and coryza, although such symptoms may be muted in transplant recipients, who may present without a rash. 5 , 6 Serious manifestations of the disease include pneumonia due to measles virus or superimposed secondary infection and acute disseminated encephalomyelitis, a demyelinating disease of the central nervous system that develops in 1:1000 cases. 5 There is no effective antiviral treatment for measles and the management is supportive. 5 Beyond the acute mortality, long-term sequelae also contribute to morbidity and delayed mortality: disability related to permanent brain damage from acute encephalomyelitis; measles inclusion body encephalitis, which occurs typically in immunocompromised individuals 6–12 mo after infection; and subacute sclerosing panencephalitis, a fatal progressive neurodegenerative disease that occurs years later in roughly 1:10 000 of cases. 1 , 5 , 7 Rates and outcomes in immunocompromised patients are largely unstudied; as with so many other infections, they are likely at higher risk for severe outcomes. 6

immunology,surgery,transplantation
Study to Assess the Clinical and Sociodemographic Profile of Measles in Children Admitted to a Tertiary Care Center: A Retrospective Study

Sagar V,Shivaprakash C Sosale,Sahana Devadas,Sujatha P,Gayathri Devi Chinnappa

DOI: https://doi.org/10.7759/cureus.65843

2024-07-31

Cureus

Abstract:Background Measles remains a significant contributor to illness and death among young children, despite the presence of a safe and efficacious vaccine. One of the most highly transmissible viruses affecting humans is measles, which can be almost entirely prevented through vaccination. The recent surge in measles cases worldwide has been particularly notable in India. A total of 172 confirmed outbreaks of measles were recorded between October 2021 and September 2022, resulting in 12,589 cases. Measles, being highly contagious, is transmitted through the respiratory route. The disease affects 75 to 90% of susceptible household contacts, reaching peak infectivity three days before the rash emerges. The recent measles outbreak observed since January 2023 holds significance, as Bangalore district alone has reported around 500 cases. Therefore, the current study aims to evaluate the clinical and sociodemographic characteristics of measles in pediatric patients. Methods This was a retrospective study conducted over seven months. Data pertaining to demographics such as age, gender, parental occupation, parental educational background, and housing situation were gathered. Details regarding the child's immunization status, the onset of fever, and the onset of rash were also documented. Descriptive data was represented using mean, standard deviation, and percentage or proportion. Results Over the study period of seven months, 53 children were admitted due to measles. The majority of the individuals were female, accounting for 28 cases (52.8%). The typical clinical manifestations of measles such as cough, coryza, and conjunctivitis were documented in 45 (84.90%), 43 (81.13%), and 32 (60.37%) children, respectively. Specifically, two (3.77%), 14 (26.41%), 20 (37.73%), and 17 (32.07%) individuals were categorized as belonging to the upper middle, lower middle, upper lower, and lower socioeconomic strata. Six children in the nine- to 12-month age range had not received the measles-rubella (MR) vaccination. Thirteen (54.16%) out of 24 children aged one to five years had not received a single dose of the vaccine, while the children who had received at least one dose did not experience any complications. Among children aged less than nine months, nine to 12 months, and more than 12 months, three (100%), two (66.6%), and three (75%) respectively, experienced complications. All the patients recovered completely and were discharged from the hospital. Conclusion Measles is re-emerging as an infectious disease among children, as evidenced by the current outbreak. Study indicates that measles tends to impact infants and under five children more frequently. Through prompt and suitable medical intervention, all affected children experienced full recovery. It was observed that immunized children had fewer complications in comparison to their non-immunized counterparts. Acquiring a thorough understanding of the clinical profile of the illness is crucial for policymakers in developing essential guidelines for measles immunization coverage.
Measles: Millions of children missed routine vaccination last year, WHO and CDC warn

Carla Delgado

DOI: https://doi.org/10.1136/bmj.q2541

2024-11-20

BMJ

Abstract:Inadequate vaccination coverage drove the number of measles cases to an estimated 10.3 million worldwide in 2023, the World Health Organization and the US Centers for Disease Control and Prevention have said in a joint report.1Coverage of at least 95% of children with two doses of the vaccine is needed to prevent outbreaks and protect communities. However, over 22 million children missed the first dose of a measles containing vaccine (MCV1) last year, reporting an immunity gap that stands in the way of elimination of the disease, said the report, published on 14 November.The estimated global coverage of MCV1 reached a peak of 86% in 2019, before declining to 81% in 2021 because of the covid-19 pandemic. Although coverage improved to 83% in 2022, it remained unchanged in 2023. No WHO region has regained its peak coverage levels.If vaccination coverage does not outpace a rapidly growing population, the number of...

medicine, general & internal

Measles Cases Are Spreading in the US—Here’s What to Know

Quantifying the risk of measles importation and spread in the United States in 2024

The Resurgence of Measles: A Rash From the Past

Epidemiologic Analysis of a Postelimination Measles Outbreak in Ohio, 2022-2023

What to Know About Monkeypox

A Call to Action: Strengthening Vaccine Confidence in the United States

Measles surge causes alarm: what scientists think

Measles hospitalizations, United States, 1985-2002

Public Health Consequences of a 2013 Measles Outbreak in New York City

Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019

The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Post-Elimination Era, 2001-2022

Measles Outbreak in Lebanon: July 2023

Ongoing Measles in the Developed and Developing World

Measles outbreak in the adult age group: Clinical, laboratory, and epidemiological features of the 11 patients admitted to the hospital

Measles resurgence in Armenia: unmasking health system vulnerabilities and crafting comprehensive eradication strategies - a review

Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels — United States, May 2022–April 2023

Measles and Measles Vaccination: A Review

Global resurgence of measles in the vaccination era and influencing factors

The Next Outbreak Looms on the Horizon: Measles and Potential Impacts on Transplant Recipients

Study to Assess the Clinical and Sociodemographic Profile of Measles in Children Admitted to a Tertiary Care Center: A Retrospective Study

Measles: Millions of children missed routine vaccination last year, WHO and CDC warn